Once-daily dosing in dogs optimizes daptomycin safety

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 11, 2000, Pages 2948-2953

  Oleson F B , Jr ^a   Berman, C L ^a   Kirkpatrick, J B ^a   Regan, K S ^a   Lai, J J ^a   Tally, F P ^a  

^a CUBIST PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; DAPTOMYCIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOG; DOSE CALCULATION; DRUG BLOOD LEVEL; DRUG INDUCED DISEASE; DRUG SAFETY; ENZYME ACTIVITY; HISTOPATHOLOGY; MALE; MYOPATHY; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE;

ANIMALS; ANTI-BACTERIAL AGENTS; DAPTOMYCIN; DOGS; MALE; MUSCLE, SKELETAL;

EID: 0033752278     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.11.2948-2953.2000     Document Type: Article

References (11)

1. Destruction and regeneration of skeletal muscle after treatment with a local anaesthetic, bupivacaine (Marcaine®)
2. Lipoteichoic acid as a new target for activity of antibiotics: Mode of action of daptomycin (LY146032)
3. Muscle function after exercise-induced muscle damage and rapid adaptation
4. 2+ and albumin on these drugs
5. Daptomycin compared with teicoplanin and vancomycin for therapy of experimental Staphylococcus aureus endocarditis
6. Effect of protein binding of daptomycin on MIC and antibacterial activity
7. Pharmacokinetics and bactericidal rates of daptomycin and vancomycin in intravenous drug abusers being treated for gram-positive endocarditis and bacteremia
8. Creatine kinase in serum. 1. Determination of optimum reaction conditions
9. Daptomycin: A novel agent for Gram-positive infections
10. Cardiovascular and skeletal muscle systems
11. Single-dose pharmacokinetics and antibacterial activity of daptomycin, a new lipopeptide antibiotic, in healthy volunteers